×
About 7,430 results

ALLMedicine™ Diabetic Ketoacidosis Center

Research & Reviews  1,908 results

EFFICACY AND SAFETY OF BEXAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SYSTE...
https://doi.org/10.1111/dom.15051
Diabetes, Obesity & Metabolism; Pasqualotto E, Maintinguer RDS et. al.

Mar 18th, 2023 - To assess the efficacy of bexagliflozin in reducing glycated hemoglobin (HbA1c) and the occurrence of side effects in patients with type 2 diabetes (DM2). We searched PubMed, Embase, Cochrane and ClinicalTrials.gov databases for placebo-controlled...

Real-World Use of Control-IQ™ Technology Automated Insulin Delivery in Pregnancy: A Cas...
https://doi.org/10.1111/dme.15086
Diabetic Medicine : a Journal of the British Diabetic Ass... Wang XS, Dunlop AD et. al.

Mar 17th, 2023 - Most commercially available automated insulin delivery (AID) systems are not approved for pregnancy use. Information regarding use of the Tandem t:slim X2 insulin pump with Control-IQ™ technology in pregnancy is lacking. This case series aimed to ...

Establishing Pragmatic Analytical Performance Specifications for Blood Beta-Hydroxybuty...
https://doi.org/10.1093/clinchem/hvad020
Clinical Chemistry; Kilpatrick ES, Butler AE et. al.

Mar 16th, 2023 - Currently, no authoritative guidelines exist recommending the analytical performance specification (APS) of blood beta-hydroxybutyrate (BOHB) testing in order to meet the clinical needs of patients. This study has applied existing diabetic ketoaci...

COVID-19-associated mucormycosis: A systematic review and meta-analysis of 958 cases.
https://doi.org/10.1016/j.cmi.2023.03.008
Clinical Microbiology and Infection : the Official Public... Özbek L, Topçu U et. al.

Mar 16th, 2023 - Mucormycosis, a rare fungal infection, has shown an increase in the number of reported cases during the COVID-19 pandemic. To provide a comprehensive insight into the characteristics of COVID-19-associated mucormycosis (CAM), through a systematic ...

Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
https://doi.org/10.1056/NEJMoa2210834
The New England Journal of Medicine; Wadwa RP, Reed ZW et. al.

Mar 16th, 2023 - Closed-loop control systems of insulin delivery may improve glycemic outcomes in young children with type 1 diabetes. The efficacy and safety of initiating a closed-loop system virtually are unclear. In this 13-week, multicenter trial, we randomly...

see more →

Guidelines  6 results

Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904174/
Diabetes & Metabolism; Sasaki H, Itoh A et. al.

Jul 3rd, 2022 - To the Editor We read with great interest the article “Fulminant type 1 diabetes (T1DM) after Covid-19 vaccination” by Tang et al. in this journal [1]. The authors examined islet autoantibodies, HLA alleles, and the capacity for insulin secreti...

ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID...
https://doi.org/10.1111/pedi.13118
Pediatric Diabetes; Priyambada L, Wolfsdorf JI et. al.

Sep 17th, 2020 - The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA ...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 11th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

Dying well with diabetes.
https://doi.org/10.21037/apm.2018.12.10
Annals of Palliative Medicine; James J

Jan 30th, 2019 - Death is an inevitable part of living. There are undoubtedly clinical and psychological challenges when any individual is passing from life to death. For a person with a long-term condition such as diabetes, these challenges can be compounded and ...

see more →

Drugs  439 results see all →

Clinicaltrials.gov  122 results

Intravenous Fluids in Adults With Diabetic Ketoacidosis in the Emergency Department
https://clinicaltrials.gov/ct2/show/NCT04926740

Mar 8th, 2023 - BACKGROUND AND SIGNIFICANCE Diabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes which requires treatment with intravenous (IV) fluid and insulin to correct hyperglycemia and reverse acidosis. Current DKA management g...

Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
https://clinicaltrials.gov/ct2/show/NCT05752279

Mar 2nd, 2023 - DKA is a life-threatening complication of diabetes mellitus, described in patients with both type-1 diabetes, and type-2 diabetes(1). Data from the Australian Institute of Health and Welfare suggest that between 2009-10 to 2014-15, there has been ...

Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in China
https://clinicaltrials.gov/ct2/show/NCT05726461

Feb 27th, 2023 - All participants will be free to live during the study.Each intervention phase is 12 weeks, preceded by a 2-week training period and separated by a 2-week washout period. During the training period, eligible participants will be trained to use the...

Use of Blood Ketone Meters to Improve Ambulance Hyperglycaemia Care
https://clinicaltrials.gov/ct2/show/NCT04940897

Feb 24th, 2023 - Diabetic ketoacidosis (DKA) is a potentially life-threatening condition which requires immediate treatment. National Health Service (NHS) hospital guidelines recommend immediate fluid (saline) therapy. Delays in diagnosis and treatment are known t...

Hyperglycemia in Neurosurgery
https://clinicaltrials.gov/ct2/show/NCT05236751

Feb 8th, 2023 - This is a multisite [3 locations] prospective observational study of adult patients (18-89 years old) scheduled for elective intracranial (open or endoscopic) procedures that require general anesthesia and a hospital stay of at least 1 day after t...

see more →

News  486 results

Another Artificial Pancreas a Success in Tots With Type 1 Diabetes
https://www.medpagetoday.com/endocrinology/type1diabetes/103548

Mar 15th, 2023 - Very young children with type 1 diabetes saw glycemic benefits when using a hybrid closed-loop system, the randomized PEDAP trial showed. Among 102 children ages 2 to 5 years, the mean percentage of time that the glucose level was within the targe...

Calcium Channel Blocker Preserves Some Beta Cell Function in Early T1D
https://www.medpagetoday.com/endocrinology/type1diabetes/103258

Feb 24th, 2023 - A calcium channel blocker helped to partially preserve stimulated C-peptide secretion in kids with newly diagnosed type 1 diabetes, although more intensive management did not, according to a randomized clinical trial. Children and adolescents who ...

Dexcom G7 CGM Covered by Medicare; T1D Off-Label Drug Use; Another Tepezza Lawsuit
https://www.medpagetoday.com/endocrinology/generalendocrinology/103194

Feb 21st, 2023 - Dexcom announced that its G7 continuous glucose monitoring (CGM) system is now available to all Medicare patients with diabetes who meet the eligibility criteria, following the system launch last week. Half of kids ages 5 and under don't eat a dai...

Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/372428

Diabetes is a common chronic condition and as of 2015, approximately 30 million persons in the United States had diabetes (23 million with diagnosed and 7 million with undiagnosed) (1). Diabetic ketoacidosis (DKA) is a life-threatening but prevent...

Diabetes Drug for Cats Now Approved in Humans Too
https://www.medpagetoday.com/endocrinology/diabetes/102754

Jan 23rd, 2023 - The first oral SGLT2 inhibitor approved by the FDA for treating diabetes in cats is now approved for humans with the disease, drugmaker TheracosBio announced. As an adjunct to diet and exercise, the oral treatment is indicated for adults with type...

see more →

Patient Education  11 results see all →